Skip to main content
SpringerLink
Log in

Respiratory Problems and Substance Misuse

  • Chapter
  • First Online:
Textbook of Addiction Treatment

Abstract

Respiratory problems account for a significant proportion of the organ-related morbidity associated with substance misuse. Pulmonary injury may occur as a result of direct drug-related toxicity or through an indirect effect, and the spectrum of pulmonary complications from drug abuse is wide. The treating clinician must maintain a high degree of vigilance in considering whether illicit drugs could potentially be contributory – or even the causative factor – in any patient presenting with respiratory symptoms with or without associated chest X-ray and chest imaging changes. This chapter considers the common patterns of illicit drug–related pulmonary complications. After initially discussing the non-specific respiratory complications that are common to a range of different substances of abuse, a focused description of the range of respiratory pathologies that can occur in relation to specific drugs is provided.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Selwyn PA, et al. Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS. AIDS. 1988;2(4):267–72.

    Article  CAS  Google Scholar 

  2. Hind CR. Pulmonary complications of intravenous drug misuse. 2. Infective and HIV related complications. Thorax. 1990;45(12):957–61.

    Article  CAS  Google Scholar 

  3. Gotway MB, et al. Thoracic complications of illicit drug use: an organ system approach. Radiogr. 2002;22 Spec No:S119–35.

    Article  Google Scholar 

  4. Mellinger M, et al. Epidemiological and clinical approach to the study of candidiasis caused by Candida albicans in heroin addicts in the Paris region: analysis of 35 observations. Bull Narc. 1982;34(3–4):61–81.

    CAS  Google Scholar 

  5. Deiss RG, Rodwell TC, Garfein RS. Tuberculosis and illicit drug use: review and update. Clin Infect Dis. 2009;48(1):72–82.

    Article  Google Scholar 

  6. Rehm J, et al. The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review. BMC Public Health. 2009;9:450.

    Article  Google Scholar 

  7. Ye R, et al. Clinical characteristics of septic pulmonary embolism in adults: a systematic review. Respir Med. 2014;108(1):1–8.

    Article  Google Scholar 

  8. Mathew J, et al. Clinical features, site of involvement, bacteriologic findings, and outcome of infective endocarditis in intravenous drug users. Arch Intern Med. 1995;155(15):1641–8.

    Article  CAS  Google Scholar 

  9. Moss R, Munt B. Injection drug use and right sided endocarditis. Heart. 2003;89(5):577–81.

    Article  Google Scholar 

  10. Kumar AN, et al. Marijuana “bong” pseudomonas lung infection: a detrimental recreational experience. Respirol Case Rep. 2018;6(2):e00293.

    Article  Google Scholar 

  11. Farber HW, et al. Pulmonary response to foreign body microemboli in dogs: release of neutrophil chemoattractant activity by vascular endothelial cells. Am J Respir Cell Mol Biol. 1989;1(1):27–35.

    Article  CAS  Google Scholar 

  12. Ferrer J, et al. Influence of particle size on extrapleural talc dissemination after talc slurry pleurodesis. Chest. 2002;122(3):1018–27.

    Article  Google Scholar 

  13. Nguyen ET, et al. Pulmonary complications of illicit drug use: differential diagnosis based on CT findings. J Thorac Imaging. 2007;22(2):199–206.

    Article  Google Scholar 

  14. Stern EJ, et al. Panlobular pulmonary emphysema caused by i.v. injection of methylphenidate (Ritalin): findings on chest radiographs and CT scans. AJR Am J Roentgenol. 1994;162(3):555–60.

    Article  CAS  Google Scholar 

  15. Vevaina JR, et al. Emphysema associated with talcum granulomatosis in a drug addict. South Med J. 1974;67(1):113–6.

    Article  CAS  Google Scholar 

  16. Griffith CC, Raval JS, Nichols L. Intravascular talcosis due to intravenous drug use is an underrecognized cause of pulmonary hypertension. Pulm Med. 2012;2012:617531.

    Article  CAS  Google Scholar 

  17. Siddiqui MF, Saleem S, Badireddi S. Pulmonary talcosis with intravenous drug abuse. Respir Care. 2013;58(10):e126–8.

    Article  Google Scholar 

  18. Perlino CA, Rimland D. Alcoholism, leukopenia, and pneumococcal sepsis. Am Rev Respir Dis. 1985;132(4):757–60.

    CAS  Google Scholar 

  19. Moss M, et al. Chronic alcohol abuse is associated with an increased incidence of acute respiratory distress syndrome and severity of multiple organ dysfunction in patients with septic shock. Crit Care Med. 2003;31(3):869–77.

    Article  Google Scholar 

  20. Guidot DM, et al. Ethanol ingestion via glutathione depletion impairs alveolar epithelial barrier function in rats. Am J Physiol Lung Cell Mol Physiol. 2000;279(1):L127–35.

    Article  CAS  Google Scholar 

  21. Nakayama S, Murashima N. A case of negative pressure pulmonary edema associated with acute ethanol intoxication. Intern Emerg Med. 2010;5(2):175–6.

    Article  Google Scholar 

  22. Tashkin DP, Shapiro BJ, Frank IM. Acute pulmonary physiologic effects of smoked marijuana and oral (Delta)9 -tetrahydrocannabinol in healthy young men. N Engl J Med. 1973;289(7):336–41.

    Article  CAS  Google Scholar 

  23. Tashkin DP, et al. Bronchial effects of aerosolized delta 9-tetrahydrocannabinol in healthy and asthmatic subjects. Am Rev Respir Dis. 1977;115(1):57–65.

    CAS  Google Scholar 

  24. Williams SJ, Hartley JP, Graham JD. Bronchodilator effect of delta1-tetrahydrocannabinol administered by aerosol of asthmatic patients. Thorax. 1976;31(6):720–3.

    Article  CAS  Google Scholar 

  25. Bloom JW, et al. Respiratory effects of non-tobacco cigarettes. Br Med J (Clin Res Ed). 1987;295(6612):1516–8.

    Article  CAS  Google Scholar 

  26. Kempker JA, Honig EG, Martin GS. The effects of marijuana exposure on expiratory airflow. A study of adults who participated in the U.S. National Health and Nutrition Examination Study. Ann Am Thorac Soc. 2015;12(2):135–41.

    Article  Google Scholar 

  27. Joshi M, Joshi A, Bartter T. Marijuana and lung diseases. Curr Opin Pulm Med. 2014;20(2):173–9.

    Article  CAS  Google Scholar 

  28. Gilbert CR, Baram M, Cavarocchi NC. “Smoking wet”: respiratory failure related to smoking tainted marijuana cigarettes. Tex Heart Inst J. 2013;40(1):64–7.

    Google Scholar 

  29. Zhang LR, et al. Cannabis smoking and lung cancer risk: pooled analysis in the International Lung Cancer Consortium. Int J Cancer. 2015;136(4):894–903.

    Article  CAS  Google Scholar 

  30. Scheel AH, et al. Talcum induced pneumoconiosis following inhalation of adulterated marijuana, a case report. Diagn Pathol. 2012;7:26.

    Article  Google Scholar 

  31. do Nascimento TS, et al. Methemoglobinemia: from diagnosis to treatment. Rev Bras Anestesiol. 2008;58(6):651–64.

    Article  Google Scholar 

  32. Mishra DR, et al. Air due to Glue: spontaneous pneumothorax in a young adult with Glue Sniffing. JNMA J Nepal Med Assoc. 2018;56(210):621–4.

    Article  Google Scholar 

  33. Schikler KN, et al. Solvent abuse associated pulmonary abnormalities. Adv Alcohol Subst Abuse. 1984;3(3):75–81.

    Article  CAS  Google Scholar 

  34. Robert R, et al. Severe Goodpasture’s syndrome after glue sniffing. Nephrol Dial Transplant. 1988;3(4):483–4.

    Article  CAS  Google Scholar 

  35. Hara M, et al. Hydrocarbon pneumonitis caused by the inhalation of wood preservative. Respirol Case Rep. 2018;6(9):e00379.

    Article  Google Scholar 

  36. Schloneger M, Stull A, Singer JI. Inhalant abuse: a case of hemoptysis associated with halogenated hydrocarbons abuse. Pediatr Emerg Care. 2009;25(11):754–7.

    Article  Google Scholar 

  37. Kurniali PC, et al. Inhalant abuse of computer cleaner manifested as angioedema. Am J Emerg Med. 2012;30(1):265 e3–5.

    Article  Google Scholar 

  38. Radke JB, et al. The effects of opioids on the lung. Clin Rev Allergy Immunol. 2014;46(1):54–64.

    Article  CAS  Google Scholar 

  39. Pathan H, Williams J. Basic opioid pharmacology: an update. Br J Pain. 2012;6(1):11–6.

    Article  Google Scholar 

  40. Miller DR, Harden JL, Currie GP. A case of self-inflicted bilateral pneumothorax. Resuscitation. 2006;71(1):122–3.

    Article  Google Scholar 

  41. Hillstrom RP, Cohn AM, McCarroll KA. Vocal cord paralysis resulting from neck injections in the intravenous drug use population. Laryngoscope. 1990;100(5):503–6.

    Article  CAS  Google Scholar 

  42. Alexander D, Alexander K, Valentino J. Intranasal hydrocodone-acetaminophen abuse induced necrosis of the nasal cavity and pharynx. Laryngoscope. 2012;122(11):2378–81.

    Article  CAS  Google Scholar 

  43. Cygan J, Trunsky M, Corbridge T. Inhaled heroin-induced status asthmaticus: five cases and a review of the literature. Chest. 2000;117(1):272–5.

    Article  CAS  Google Scholar 

  44. Pattinson KT. Opioids and the control of respiration. Br J Anaesth. 2008;100(6):747–58.

    Article  CAS  Google Scholar 

  45. Wang D, et al. Central sleep apnea in stable methadone maintenance treatment patients. Chest. 2005;128(3):1348–56.

    Article  Google Scholar 

  46. Streisand JB, et al. Fentanyl-induced rigidity and unconsciousness in human volunteers. Incidence, duration, and plasma concentrations. Anesthesiology. 1993;78(4):629–34.

    Article  CAS  Google Scholar 

  47. Mell HK, Sztajnkrycer MD. Clinical images in medical toxicology: heroin overdose with non-cardiogenic pulmonary edema. Clin Toxicol. 2006;44(4):399.

    Article  Google Scholar 

  48. Kienbaum P, et al. Profound increase in epinephrine concentration in plasma and cardiovascular stimulation after mu-opioid receptor blockade in opioid-addicted patients during barbiturate-induced anesthesia for acute detoxification. Anesthesiology. 1998;88(5):1154–61.

    Article  CAS  Google Scholar 

  49. Brander PE, Tukiainen P. Acute eosinophilic pneumonia in a heroin smoker. Eur Respir J. 1993;6(5):750–2.

    Article  CAS  Google Scholar 

  50. Traclet J, et al. Pulmonary arterial hypertension in heroin users. J Heart Lung Transplant. 2016;35(7):932–4.

    Article  Google Scholar 

  51. Cruickshank CC, Dyer KR. A review of the clinical pharmacology of methamphetamine. Addiction. 2009;104(7):1085–99.

    Article  Google Scholar 

  52. Goodchild JH, Donaldson M. Methamphetamine abuse and dentistry: a review of the literature and presentation of a clinical case. Quintessence Int. 2007;38(7):583–90.

    Google Scholar 

  53. Pourmotabed S, Jalili M. Pneumomediastinum following crystal use: a report of two cases. Case Rep Emerg Med. 2016;2016:9730484.

    Google Scholar 

  54. Marasco SF, Lim HK. Ecstasy-associated pneumomediastinum. Ann R Coll Surg Engl. 2007;89(4):389–93.

    Article  Google Scholar 

  55. Chang SH, et al. MDMA-induced acute pulmonary edema in a patient without other organ dysfunction. Am J Emerg Med. 2006;24(6):734–6.

    Article  Google Scholar 

  56. Nestor TA, et al. Acute pulmonary oedema caused by crystalline methamphetamine. Lancet. 1989;2(8674):1277–8.

    Article  CAS  Google Scholar 

  57. Fowler AH, Majithia V. Ultimate mimicry: methamphetamine-induced pseudovasculitis. Am J Med. 2015;128(4):364–6.

    Article  Google Scholar 

  58. Zamanian RT, et al. Features and outcomes of methamphetamine-associated pulmonary arterial hypertension. Am J Respir Crit Care Med. 2018;197(6):788–800.

    Article  CAS  Google Scholar 

  59. Brownlow HA, Pappachan J. Pathophysiology of cocaine abuse. Eur J Anaesthesiol. 2002;19(6):395–414.

    Article  CAS  Google Scholar 

  60. Warner EA. Cocaine abuse. Ann Intern Med. 1993;119(3):226–35.

    Article  CAS  Google Scholar 

  61. Broseus J, et al. Qualitative, quantitative and temporal study of cutting agents for cocaine and heroin over 9 years. Forensic Sci Int. 2015;257:307–13.

    Article  CAS  Google Scholar 

  62. Ciccarone D. Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy. Prim Care. 2011;38(1):41–58.

    Article  Google Scholar 

  63. Itkonen J, Schnoll S, Glassroth J. Pulmonary dysfunction in ‘freebase’ cocaine users. Arch Intern Med. 1984;144(11):2195–7.

    Article  CAS  Google Scholar 

  64. Tashkin DP, et al. Pulmonary status of habitual cocaine smokers. Am Rev Respir Dis. 1992;145(1):92–100.

    Article  CAS  Google Scholar 

  65. Schwartz RH, et al. Nasal symptoms associated with cocaine abuse during adolescence. Arch Otolaryngol Head Neck Surg. 1989;115(1):63–4.

    Article  CAS  Google Scholar 

  66. You P, et al. Velopharyngeal dysfunction from intranasal substance abuse: case series and review of literature. Laryngoscope. 2018;128(12):2721–5.

    Article  Google Scholar 

  67. Walker A, Joshi A, D’Souza A. Care of the Cocaine user with Nasal Deformity. Facial Plast Surg. 2017;33(4):411–8.

    Article  CAS  Google Scholar 

  68. de Lange J, et al. The effect of nasal application of cocaine/adrenaline on blood loss in Le Fort I osteotomies. Int J Oral Maxillofac Surg. 2008;37(1):21–4.

    Article  Google Scholar 

  69. Wiesner O, et al. Antineutrophil cytoplasmic antibodies reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis. Arthritis Rheum. 2004;50(9):2954–65.

    Article  CAS  Google Scholar 

  70. Rachapalli SM, Kiely PD. Cocaine-induced midline destructive lesions mimicking ENT-limited Wegener’s granulomatosis. Scand J Rheumatol. 2008;37(6):477–80.

    Article  CAS  Google Scholar 

  71. Perez Alamino R, Espinoza LR. Vasculitis mimics: cocaine-induced midline destructive lesions. Am J Med Sci. 2013;346(5):430–1.

    Article  Google Scholar 

  72. Hidalgo Mora JJ, et al. Uvular angioedema after intranasal cocaine consumption. Med Clin (Barc). 2002;119(11):438–9.

    Article  Google Scholar 

  73. Silverman RS, Lee-Chiong TL Jr, Sherter CB. Stridor from edema of the arytenoids, epiglottis, and vocal cords after use of free-base cocaine. Chest. 1995;108(5):1477–8.

    Article  CAS  Google Scholar 

  74. Desai DP, et al. Bilateral saccular cysts after cocaine use. Otolaryngol Head Neck Surg. 1999;120(5):754–7.

    Article  CAS  Google Scholar 

  75. Armentia A, et al. Cocaine allergy in drug-dependent patients and allergic people. J Allergy Clin Immunol Pract. 2018;6(1):201–7.

    Article  Google Scholar 

  76. Rubin RB, Neugarten J. Cocaine-associated asthma. Am J Med. 1990;88(4):438–9.

    Article  CAS  Google Scholar 

  77. Osborn HH, et al. New-onset bronchospasm or recrudescence of asthma associated with cocaine abuse. Acad Emerg Med. 1997;4(7):689–92.

    Article  CAS  Google Scholar 

  78. Leitman BS, Greengart A, Wasser HJ. Pneumomediastinum and pneumopericardium after cocaine abuse. AJR Am J Roentgenol. 1988;151(3):614.

    Article  CAS  Google Scholar 

  79. Alqalyoobi S, et al. Cocaine induced pleural and pericardial effusion syndrome. Case Rep Pulmonol. 2015;2015:321539.

    Google Scholar 

  80. Strong DH, et al. Eosinophilic “empyema” associated with crack cocaine use. Thorax. 2003;58(9):823–4.

    Article  CAS  Google Scholar 

  81. Rezkalla SH, Kloner RA. Cocaine-induced acute myocardial infarction. Clin Med Res. 2007;5(3):172–6.

    Article  Google Scholar 

  82. Willetts J, et al. Effects of methylecgonidine on acetylcholine-induced bronchoconstriction and indicators of lung injury in guinea pigs. Life Sci. 1995;57(15):PL225–30.

    Article  CAS  Google Scholar 

  83. Bailey ME, et al. Pulmonary histopathology in cocaine abusers. Hum Pathol. 1994;25(2):203–7.

    Article  CAS  Google Scholar 

  84. Forrester JM, et al. Crack lung: an acute pulmonary syndrome with a spectrum of clinical and histopathologic findings. Am Rev Respir Dis. 1990;142(2):462–7.

    Article  CAS  Google Scholar 

  85. Oh PI, Balter MS. Cocaine induced eosinophilic lung disease. Thorax. 1992;47(6):478–9.

    Article  CAS  Google Scholar 

  86. McGrath MM, et al. Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease. Clin J Am Soc Nephrol. 2011;6(12):2799–805.

    Article  Google Scholar 

  87. Nolan AL, Jen KY. Pathologic manifestations of levamisole-adulterated cocaine exposure. Diagn Pathol. 2015;10:48.

    Article  CAS  Google Scholar 

  88. Tseng W, Sutter ME, Albertson TE. Stimulants and the lung : review of literature. Clin Rev Allergy Immunol. 2014;46(1):82–100.

    Article  CAS  Google Scholar 

  89. Murray RJ, et al. Pulmonary artery medial hypertrophy in cocaine users without foreign particle microembolization. Chest. 1989;96(5):1050–3.

    Article  CAS  Google Scholar 

  90. Ramachandaran S, et al. Inhalation of crack cocaine can mimic pulmonary embolism. Clin Nucl Med. 2004;29(11):756–7.

    Article  Google Scholar 

  91. Delaney K, Hoffman RS. Pulmonary infarction associated with crack cocaine use in a previously healthy 23-year-old woman. Am J Med. 1991;91(1):92–4.

    Article  CAS  Google Scholar 

  92. Karch SB, et al. Aminorex associated with possible idiopathic pulmonary hypertension in a cocaine user. Forensic Sci Int. 2014;240:e7–10.

    Article  CAS  Google Scholar 

  93. Bonekat HW, Miles RM, Staats BA. Smoking and cough syncope: follow-up in 45 cases. Int J Addict. 1987;22(5):413–9.

    Article  CAS  Google Scholar 

  94. Huttunen R, Heikkinen T, Syrjanen J. Smoking and the outcome of infection. J Intern Med. 2011;269(3):258–69.

    Article  CAS  Google Scholar 

  95. Nuorti JP, et al. Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med. 2000;342(10):681–9.

    Article  CAS  Google Scholar 

  96. Almirall J, et al. Proportion of community-acquired pneumonia cases attributable to tobacco smoking. Chest. 1999;116(2):375–9.

    Article  CAS  Google Scholar 

  97. Hamari A, et al. High frequency of chronic cough and sputum production with lowered exercise capacity in young smokers. Ann Med. 2010;42(7):512–20.

    Article  Google Scholar 

  98. Blanc FX, et al. Capsaicin cough sensitivity in smokers with and without airflow obstruction. Respir Med. 2009;103(5):786–90.

    Article  Google Scholar 

  99. Rycroft CE, et al. Epidemiology of chronic obstructive pulmonary disease: a literature review. Int J Chron Obstruct Pulmon Dis. 2012;7:457–94.

    Article  Google Scholar 

  100. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J. 1977;1(6077):1645–8.

    Article  CAS  Google Scholar 

  101. Burchfiel CM, et al. Effects of smoking and smoking cessation on longitudinal decline in pulmonary function. Am J Respir Crit Care Med. 1995;151(6):1778–85.

    Article  CAS  Google Scholar 

  102. Woodruff PG, et al. Clinical significance of symptoms in smokers with preserved pulmonary function. N Engl J Med. 2016;374(19):1811–21.

    Article  CAS  Google Scholar 

  103. Piantadosi CA. Carbon monoxide poisoning. N Engl J Med. 2002;347(14):1054–5.

    Article  Google Scholar 

  104. McDonough P, Moffatt RJ. Smoking-induced elevations in blood carboxyhaemoglobin levels. Effect on maximal oxygen uptake. Sports Med. 1999;27(5):275–83.

    Article  CAS  Google Scholar 

  105. Strachan DP, Butland BK, Anderson HR. Incidence and prognosis of asthma and wheezing illness from early childhood to age 33 in a national British cohort. BMJ. 1996;312(7040):1195–9.

    Article  CAS  Google Scholar 

  106. Vesterinen E, Kaprio J, Koskenvuo M. Prospective study of asthma in relation to smoking habits among 14,729 adults. Thorax. 1988;43(7):534–9.

    Article  CAS  Google Scholar 

  107. Vassallo R, Ryu JH. Smoking-related interstitial lung diseases. Clin Chest Med. 2012;33(1):165–78.

    Article  Google Scholar 

  108. Caminati A, et al. An integrated approach in the diagnosis of smoking-related interstitial lung diseases. Eur Respir Rev. 2012;21(125):207–17.

    Article  Google Scholar 

  109. Baumgartner KB, et al. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1997;155(1):242–8.

    Article  CAS  Google Scholar 

  110. Johnson C. Recent advances in the pathogenesis, prediction, and management of rheumatoid arthritis-associated interstitial lung disease. Curr Opin Rheumatol. 2017;29(3):254–9.

    Article  Google Scholar 

  111. Philit F, et al. Idiopathic acute eosinophilic pneumonia: a study of 22 patients. Am J Respir Crit Care Med. 2002;166(9):1235–9.

    Article  Google Scholar 

  112. Janz DR, O’Neal HR, Ely EW. Acute eosinophilic pneumonia: a case report and review of the literature. Crit Care Med. 2009;37(4):1470–4.

    Article  Google Scholar 

  113. Morabia A, Wynder EL. Cigarette smoking and lung cancer cell types. Cancer. 1991;68(9):2074–8.

    Article  CAS  Google Scholar 

  114. Thun MJ, et al. Cigarette smoking and changes in the histopathology of lung cancer. J Natl Cancer Inst. 1997;89(21):1580–6.

    Article  CAS  Google Scholar 

  115. Peto R, et al. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ. 2000;321(7257):323–9.

    Article  CAS  Google Scholar 

  116. Kaur G, et al. Immunological and toxicological risk assessment of e-cigarettes. Eur Respir Rev. 2018;27(147):170119.

    Article  Google Scholar 

  117. Layden JE, et al. Pulmonary illness related to E-Cigarette Use in Illinois and Wisconsin – Preliminary report. N Engl J Med. 2020;382:903–16.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Respiratory & Sleep Medicine, Royal Prince Alfred Hospital, Camperdown, NSW, Australia

    B. Nanayakkara & S. McNamara

Authors
  1. B. Nanayakkara
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. McNamara
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. McNamara .

Editor information

Editors and Affiliations

  1. Division of Addiction Department of Psychiatry, University of Calgary, Calgary, AB, Canada

    Nady el-Guebaly

  2. Mental Health Department, University of Milano-Bicocca, Monza, Monza e Brianza, Italy

    Giuseppe Carrà

  3. Division of Alcoholism and Drug Abuse Department of Psychiatry, NYU School of Medicine, New York, NY, USA

    Marc Galanter

  4. Population and Behavioural Science Division (Psychiatry and Addictions), University of St Andrews, St.Andrews, UK

    Alexander M. Baldacchino

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Nanayakkara, B., McNamara, S. (2021). Respiratory Problems and Substance Misuse. In: el-Guebaly, N., Carrà, G., Galanter, M., Baldacchino, A.M. (eds) Textbook of Addiction Treatment. Springer, Cham. https://doi.org/10.1007/978-3-030-36391-8_74

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-36391-8_74

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-36390-1

  • Online ISBN: 978-3-030-36391-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation